Ra Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Ra Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ra Pharmaceuticals Inc Strategy Report
- Understand Ra Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ra Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022177635A2 | Application | COMPOSITIONS AND METHODS FOR MICROBIAL DISEASE TREATMENT | A61K38/00; Y02A50/30 | August 25, 2022 |
US20220257697A1 | Application | INFLAMMATORY DISEASE TREATMENT WITH COMPLEMENT INHIBITORS | A61K35/16; A61K38/12; A61M5/329; A61P21/00; C07K16/2887; C07K2317/24; G01N33/564 | August 18, 2022 |
US20220233632A1 | Application | MODULATORS OF COMPLEMENT ACTIVITY | A61K38/12; A61K39/3955; A61K9/0019; A61P7/06 | July 28, 2022 |
EP4028126A1 | Application | BEHANDLUNG EINER NEUROLOGISCHEN ERKRANKUNG MIT KOMPLEMENTINHIBITOREN | A61K38/12; A61P21/00; A61P21/04; G01N2333/4716; G01N2800/2835; G01N2800/50; G01N2800/52; G01N33/564; G01N33/6896; Y02A50/30 | July 20, 2022 |
US20220211799A1 | Application | COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT ACTIVITY | A61K38/12; A61K47/32; A61K9/107; A61K9/1605; A61K9/1647 | July 07, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer